PAM
ACHV icon

Panagora Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Panagora Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-208
Closed -$13K – 2448
2018
Q3 		$13K Hold
208
– – ﹤0.01% 2276
2018
Q2 		$16K Sell
208
-65
-24% -$13.2K ﹤0.01% 2213
2018
Q1 		$69K Hold
273
– – ﹤0.01% 1943
2017
Q4 		$74K Buy
273
+9
+3% +$2.88K ﹤0.01% 1965
2017
Q3 		$107K Sell
264
-99
-27% -$71.1K ﹤0.01% 1868
2017
Q2 		$287K Sell
363
-24
-6% -$19.5K ﹤0.01% 1515
2017
Q1 		$377K Sell
387
-45
-10% -$54.6K ﹤0.01% 1453
2016
Q4 		$475K Hold
432
– – ﹤0.01% 1469
2016
Q3 		$481K Buy
432
+371
+608% +$591K ﹤0.01% 1467
2016
Q2 		$134K Sell
61
-84
-58% -$175K ﹤0.01% 1817
2016
Q1 		$219K Buy
145
+102
+237% +$166K ﹤0.01% 1626
2015
Q4 		$115K Buy
+43
New +$182K ﹤0.01% 1759
2014
Q3 		– Hold
0
– -$2K – 2277
2014
Q2 		– Hold
0
– – – 2312
2014
Q1 		– Hold
0
– – – 2285

Other funds holding ACHV

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Panagora Asset Management's ACHV Position: Q4 2018 in Review

Panagora Asset Management sold out of Achieve Life Sciences (ACHV) in Q4 2018, closing a stake of 208 shares — an estimated $13K sold.

Panagora Asset Management first reported a position in ACHV in Q4 2015 and held it in 12 quarters. The position peaked at $481K in Q3 2016. 11 funds tracked by Wall St. Rank hold ACHV as of Q4 2018.

  • Panagora Asset Management reported no remaining Achieve Life Sciences position as of Q4 2018 after selling out during the quarter.
  • Panagora Asset Management sold 208 Achieve Life Sciences shares in Q4 2018, an estimated $13K.
  • Panagora Asset Management first reported a position in Achieve Life Sciences in Q4 2015 and held it in 12 quarters.
  • Panagora Asset Management's Achieve Life Sciences position peaked at $481K in Q3 2016.
  • 11 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2018.

Based on Panagora Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.